Committee
Committee
Scientific
Committee
Stefano Aliberti (Italy)
Professor of Respiratory Medicine, Humanitas University (Milano – Italy)
Chief of Respiratory Unit – IRCCS Humanitas Research Hospital (Milano – Italy)
Medical Degree from the University of Milan – Clinical research training at the University of Louisville, KY, USA
Former Head of the Respiratory Infections Assembly of the European Respiratory Society
Chair of the European Bronchiectasis Network (EMBARC)
Chair of IRIDE, the Italian Registry of adult bronchiectasis
Chair of the Italian Registry on Non-Tuberculous Mycobacteria (IRENE)
Pieter Goeminne (Belgium)
Respiratory physician and staff member at AZ Nikolaas, Sint-Niklaas, Belgium
Chair of the Infectious Disease Working group of the Belgian Respiratory Society
Specialist in Bronchiectasis, reviewer for several journals and active member of the EMBARC network
Bernard Maitre (France)
Academic appointment:
Full position Professor (2002), Chief of the Department of Pulmonary Disease (2019), Medical school of Créteil, University Paris XII
Academic activities:
- 2015- Chief of the university recruitment committee, Paris Est Creteil University
- 2021-23 Président of the National College of Pulmonary Faculties
- 2018-2021President of the scientific committee, French Speaking Society of Pulmonary Disease
- Co-leader French national Bronchiectasis cohort cohorte nationale Bronchiectasie (EMBARC
- France). Leader of the national PCD Frnch cohort (Radico-PCD)
- Member of the COST ACTION then  ERS-CRC  BEAT PCD 2018-2020
- 2021- Clinical Trial Network (CTN-PCD) deputy, Coordinating Center.
- More than 200 scientific publications, h index 31 (WoS) 47 (google scholar)
Clémence Martin (France)
She is an adult respiratory medicine physician with expertise in the care of patients with bronchiectasis, including cystic fibrosis. She is a member of the National Reference Centre for Cystic Fibrosis in Paris (France) and aims to develop a Centre of Expertise to assist with the characterization of bronchiectasis patients with rare diseases and provide advice for the management of rare complications in patients with bronchiectasis.
Marlène Murris-Espin (France)
Marlène MURRIS-ESPIN is a pulmonologist at Larrey University Hospital in Toulouse (France). She works especially in the field of cystic fibrosis, bronchiectasis, respiratory infections and lung transplantation. She was a member of the Steering Committee of EMBARC (European Multicentre Bronchiectasis Registry Audit and Research Collaboration), and participated to the European Bronchiectasis Guidelines in 2017. She is the Toulouse Adult Cystic Fibrosis Center Director and a member of several respiratory societies: the GREPI (Groupe pour la Recherche et l’Enseignement en Pneumo-Infectiologie, groupe de travail de la Société de Pneumologie de Langue Française), la Societe de Pneumologie de Langue Francaise (SPLF), la Société Francaise de la Mucoviscidose (SFM), and the European Respiratory Society (ERS).
Eva Polverino (Spain)
Specialist in respiratory diseases since 2003
After achieving a PhD in cardiorespiratory pathophysiology she focussed her work in the field of respiratory infections since 2007 at the University of Barcelona (Hospital Clinic) AssociatedProfessor of the Faculty of medicine (University of Barcelona) between 2014 and 2016 anddirector of different doctoral theses and of 2 end-of-course projects. Currently Head of the research Unit in Respiratory Infections of the Department of Respiratory Diseases at Hospital Vall d’Hebron in Barcelona (VHIR, Spain).Â
Her main lines of investigation are:
1. Non cystic fibrosis bronchiectasis (NCFBE)
2. Cystic fibrosis (CF)
3. Antimicrobial resistance
4. Primary and secondary Immunodeficiencies
5. Community-acquired pneumonia (CAP)
6. Respiratory physiotherapy
She is particularly active at European level as:
1. European Respiratory Society:
a. Director of ERS relationship with the EU
b. Head of the Assembly of respiratory infections of the European Respiratory Society until September 2023
c. Head of the Group of adult Cystic Fibrosis (ERS, Assembly 10) until September 2023
d. Member of the Executive Committee and Science Council of ERS.
e. Spanish delegate for the HERMES project (Harmonising education in respiratory medicine for European specialists) in respiratory infections for ERS;
2. Co-chair of the European Registry of Bronchiectasis (EMBARC, www.bronchiectasis.eu) and clinical research collaboration of ERS.
3. Co-investigator of different EU funded projects aimed at investigating new treatments, reduce antibiotic overuse and antimicrobial resistance control:
a. EU Project: “iABC – Inhaled Antibiotics in Bronchiectasis and Cystic fibrosis”, Innovative Medicine Initiative EU 2014 Consortium EFPIA, co-leader of WP4b;
b. EU Project: “VALUE-Dx- The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use ” (ERS representative and CoLead of the Dissemination WP6)
c. EU Project: “ European Clinical Research Alliance On Infectious Diseases (ECRAID)- Base”. (ERS representative and Co-leader of WP11 (â€Education and Advocacy’)
d. European Reference Network (ERN) for the lung (ERN-LUNG) for bronchiectasis,cysticfibrosis and primary ciliary dyskinesia.
4. Principal investigator and collaborator of numerous clinical trials in respiratory infections (new drugs for CAP, CF and NCFBE) and in respiratory physiotherapy.
5. Editor for Springer and ERJ monograph, author of more than 130 scientific publications, reviewer of >10 scientific journals, and for the Spanish agency of Scientific awards/grants (ANEP).
6. Frequent speaker and moderator at scientific congresses (ERS, SEPAR, etc.) and seminars/ classes regarding infections in respiratory diseases.
7. Author of more than 100 scientific publications with over 9100 citations and h index of 51. Author of the first European Guidelines for Bronchiectasis.
Major skills: 1) promoting and leading collaborative research across different countries and
scientific disciplines, 2) scientific writing and communication 3) educational activities.
